Gliptaking Trio 15's

Gliptaking Trio 15's

Prescription drug
Manufacturer / Marketer : REDMAX PHARMA
Expiry : 30-09-2027
About: Gliptaking Trio is a triple antidiabetic for type 2 diabetes, likely combining glimepiride, metformin, and a DPP‑4 inhibitor such as teneligliptin/sitagliptin.
Usage Instructions: Dose is usually once daily with meals as directed.
Benefits: Targets multiple mechanisms including insulin secretion, resistance, and incretin pathway.
How it Works: Sulfonylurea boosts insulin, metformin improves sensitivity and reduces hepatic glucose, DPP‑4 inhibitor increases incretin‑mediated insulin release.
Side Effects: Hypoglycemia, GI upset, headache, rare pancreatitis.
Safety Advice: Regular monitoring of sugars, renal function; monitor for abdominal pain suggesting pancreatitis.
Storage: Store below 25°C.
₹261.00 MRP: ₹290.00 Save ₹29.00 (10%)
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
About: Gliptaking Trio is a triple antidiabetic for type 2 diabetes, likely combining glimepiride, metformin, and a DPP‑4 inhibitor such as teneligliptin/sitagliptin.
Usage Instructions: Dose is usually once daily with meals as directed.
Benefits: Targets multiple mechanisms including insulin secretion, resistance, and incretin pathway.
How it Works: Sulfonylurea boosts insulin, metformin improves sensitivity and reduces hepatic glucose, DPP‑4 inhibitor increases incretin‑mediated insulin release.
Side Effects: Hypoglycemia, GI upset, headache, rare pancreatitis.
Safety Advice: Regular monitoring of sugars, renal function; monitor for abdominal pain suggesting pancreatitis.
Storage: Store below 25°C.

Related Products